Interference of outer membrane protein PalA with protective immunity against Actinobacillus pleuropneumoniae infections in vaccinated pigs.

Interference of outer membrane protein PalA with protective immunity against Actinobacillus pleuropneumoniae infections in vaccinated pigs.

Item
http://www.wikidata.org/entity/Q51658529
Current Status of Veterinary VaccinesMicroarray-based comparative genomic profiling of reference strains and selected Canadian field isolates of Actinobacillus pleuropneumoniae.Immunoproteomic analysis of outer membrane proteins and extracellular proteins of Actinobacillus pleuropneumoniae JL03 serotype 3Evaluation of multicomponent recombinant vaccines against Actinobacillus pleuropneumoniae in miceVaccination of cattle with the N terminus of LppQ of Mycoplasma mycoides subsp. mycoides results in type III immune complex disease upon experimental infection.Immunogenicity of Mannheimia haemolytica recombinant outer membrane proteins serotype 1-specific antigen, OmpA, OmpP2, and OmpD15Type IV fimbrial subunit protein ApfA contributes to protection against porcine pleuropneumonia.Identification and characterization of a novel stress-responsive outer membrane protein Lip40 from Actinobacillus pleuropneumoniae.A randomized controlled study on the efficacy of a novel combination vaccine against enzootic pneumonia (Mycoplasma hyopneumoniae) and porcine Circovirus type 2 (PCV2) in the presence of strong maternally derived PCV2 immunity in pigs.Molecular mechanisms of pathogenicity of Mycoplasma mycoides subsp. mycoides SC.Identification of conserved surface proteins as novel antigenic vaccine candidates of Actinobacillus pleuropneumoniae.Identification and characterization of serovar-independent immunogens in Actinobacillus pleuropneumoniae.In vivo testing of novel vaccine prototypes against Actinobacillus pleuropneumoniae.Update on Actinobacillus pleuropneumoniae-knowledge, gaps and challenges.Efficacy of vaccination against Actinobacillus pleuropneumoniae in two Belgian farrow-to-finish pig herds with a history of chronic pleurisy.Field efficacy study of a novel ready-to-use vaccine against mycoplasma hyopneumoniae and porcine circovirus type 2 in a Greek farm.Galactose-1-phosphate uridyltransferase (GalT), an in vivo-induced antigen of Actinobacillus pleuropneumoniae serovar 5b strain L20, provided immunoprotection against serovar 1 strain MS71.
P2860

Interference of outer membrane protein PalA with protective immunity against Actinobacillus pleuropneumoniae infections in vaccinated pigs.

Item
http://www.wikidata.org/entity/Q51658529
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
2003年學術文章
@zh-hant
name
Interference of outer membrane ...... infections in vaccinated pigs.
@en
Interference of outer membrane ...... infections in vaccinated pigs.
@nl
type
label
Interference of outer membrane ...... infections in vaccinated pigs.
@en
Interference of outer membrane ...... infections in vaccinated pigs.
@nl
prefLabel
Interference of outer membrane ...... infections in vaccinated pigs.
@en
Interference of outer membrane ...... infections in vaccinated pigs.
@nl
P1433
P1476
P2093
P304
P31
P356
P407
P433
P478
P577
P698
P356
P1433
P1476
Interference of outer membrane ...... infections in vaccinated pigs.
@en
P2093
P304
P31
P356
10.1016/S0264-410X(03)00410-9
P407
P433
P478
P577
P698